Related Experiment Video
Updated: May 9, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
New steroidal 7-azaindole platinum(II) antitumor complexes
Ana Zamora1, Venancio Rodríguez, Natalia Cutillas
1Departamento de Química Inorgánica and Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia and Instituto Murciano de Investigación Biosanitaria (IMIB), Spain, E-30071 Murcia, Spain.
New platinum complexes with steroidal 7-azaindole ligands show potent anticancer activity against cisplatin-resistant ovarian and breast cancer cells. These compounds also inhibit cathepsin B and interact with DNA, indicating a promising therapeutic potential.
Area of Science:
- Medicinal Chemistry
- Inorganic Chemistry
- Cancer Research
Background:
- Development of novel platinum-based anticancer agents is crucial to overcome drug resistance.
- Steroidal scaffolds and N-donor ligands offer unique properties for drug design.
- 7-azaindole derivatives show potential in medicinal applications.
Purpose of the Study:
- To synthesize and characterize novel steroidal 7-azaindole-based N-donor ligands and their platinum complexes.
- To evaluate the in vitro anticancer activity of the new platinum complexes against human tumor cell lines.
- To investigate the DNA interaction, cathepsin B inhibitory activity, and lipophilicity of the synthesized compounds.
Main Methods:
- Synthesis and characterization of steroidal 7-azaindole ligands (ET-Haza and LEV-Haza) and platinum complexes [Pt(dmba)Cl(L)].
- In vitro cytotoxicity assays (IC50 determination) against ovarian (A2780, A2780cis) and breast (T47D) cancer cell lines, and normal renal cells (LLC-PK1).
- DNA interaction studies using ESI-MS and electrophoretic mobility assays, cathepsin B inhibition assays, and theoretical calculations.
Main Results:
- Two new steroidal 7-azaindole ligands and their platinum complexes (3 and 4) were successfully synthesized and characterized.
- Complexes 3 and 4 exhibited potent activity against cisplatin-resistant ovarian cancer cells with low resistance factors and favorable selectivity over normal renal cells.
- The complexes demonstrated DNA interaction capabilities, cathepsin B inhibition, and enhanced lipophilicity, supported by theoretical calculations.
Conclusions:
- The novel platinum complexes incorporating steroidal 7-azaindole ligands represent a promising new class of anticancer agents.
- These compounds overcome cisplatin resistance and show potential for treating ovarian and breast cancers.
- Further investigation into their mechanism of action and therapeutic efficacy is warranted.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Stereoisomerism
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drugs that Destabilize Microtubules
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Drugs that Stabilize Microtubules

